Growth and pubertal disorders in neurofibromatosis type 1

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue SUPPL. 2, 2003, Pages 289-292

  Virdis, R ^a   Street, M E ^a   Bandello, M A ^a   Tripodi, C ^a   Donadio, A ^b   Villani, A R ^a   Cagozzi, L ^a   Garaveli, L ^b   Bernasconi, S ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Arcispedale Santa Maria   (Italy)

Author keywords

Delayed puberty; GnRH agonist therapy; Growth; Neurofibromatosis type 1; Optic gliomas; Optic pathway tumors; Precocious puberty

Indexed keywords

GONADORELIN AGONIST; GONADORELIN;

ARTICLE; BODY HEIGHT; CENTRAL NERVOUS SYSTEM TUMOR; DELAYED PUBERTY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE TUMOR; GROWTH DISORDER; HUMAN; INCIDENCE; MENARCHE; NEUROFIBROMA; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PRECOCIOUS PUBERTY; PUBERTY DISORDERS; SCOLIOSIS; SHORT STATURE; STATISTICAL SIGNIFICANCE; DRUG POTENTIATION; GROWTH; OPTIC NERVE TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

BODY HEIGHT; GONADOTROPIN-RELEASING HORMONE; GROWTH; HUMANS; NEUROFIBROMATOSIS 1; OPTIC NERVE NEOPLASMS; PUBERTY, PRECOCIOUS;

EID: 0041777736     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Huson SM, Hughes RAC. The Neurofibromatoses. A Pathogenetic and Clinical Overview. London: Chapman & Hall Medical, 1994.
2. Riccardi VM, Eichner JE. Neurofibromatosis. Phenotype, Natural History and Pathogenesis. Baltimore, MA: The Johns Hopkins University Press, 1986.
3. Carmi D, Shohat M, Metzker A, Dickerman Z. Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics 1999; 103: 1257-1262.
4. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R. Neurofibromatosis type 1 growth charts. Am J Med Genet 1999; 87: 317-323.
5. Street ME, Garavelli L, Tripodi C, Donadio A, Sigorini M, Bonetti L, Villani AR, Predieri B, Bernasconi S, Virdis R. In subjects with neurofibromatosis type 1 (NF1) the average height percentile decreases with growth. Pediatr Res 2001; 49: 39A.
6. Howell SJ, Wilton P, Lindberg A, Shalet SM. Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. J Pediatr 1998; 133: 201-205.
7. Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesion. Pediatr Neurol 2000; 22: 355-358.
8. Habiby R, Silverman B, Listernick R, Charrow J. Precocious puberty in children with neurofibromatosis type 1. J Pediatr 1995; 126: 364-367.
9. Laue L, Comite F, Hench K, Loriaux DL, Cutler GB, Pescovitz OH. Precocious puberty associated with neurofibromatosis and optic gliomas. Am J Dis Child 1985; 139: 1097-1100.
10. Zacharin M. Precocious puberty in two children with neurofibromatosis type 1 in the absence of optic chiasmal glioma. J Pediatr 1997; 130: 155-157.
11. Virdis R, Sigorini M, Laiolo A, Lorenzetti E, Street ME, Villani AR, Donadio A, Pisani F, Terzi C, Garavelli L. Neurofibromatosis type 1 and precocious puberty. J Pediatr Endocrinol Metab 2000; 13: 841-844.
12. Habiby R, Silverman B, Listernick R, Charrow J. Neurofibromatosis type 1 and precocious puberty: beyond the chiasm. J Pediatr 1997; 131: 786-787.
13. Cnossen MH, Stam EN, Cooiman LCMG, Simonsz HJ, Stroink H, Oranje AP, Halley DJJ, de Goede-Bolder A, Niermeijer MF, de Muink Keizer-Schrama SMPF. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 1997; 100: 667-670.
14. Virdis R, Street ME, Tripodi C, Bandello MA, Grassi L, Sigorini M, Terzi C. Delayed and not precocious puberty is the most frequent pubertal disorder in neurofibromatosis 1 (NF1). Pediatr Res 2001; 49: 137A.